A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications
Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department
|3||Not yet recruiting||
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-2) Trial - THE CHART-2 TRIAL
|4||Active, not recruiting||
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
|5||Active, not recruiting||
Safety and Efficacy of Autologous Cardiopoietic Cells for Treatment of Ischemic Heart Failure.
C-Cure Clinical Trial
† Study has passed its completion date and status has not been verified in more than two years.